-DOCSTART- -X- O
Background -X- _ O
: -X- _ O
In -X- _ O
Africa -X- _ O
, -X- _ O
the -X- _ O
clinical -X- _ O
syndrome -X- _ O
of -X- _ O
pneumonia -X- _ B-Patient
remains -X- _ O
the -X- _ O
leading -X- _ O
cause -X- _ O
of -X- _ O
morbidity -X- _ O
and -X- _ O
mortality -X- _ O
in -X- _ O
children -X- _ O
in -X- _ O
the -X- _ O
post-neonatal -X- _ O
period. -X- _ O
This -X- _ O
represents -X- _ O
a -X- _ O
significant -X- _ O
burden -X- _ O
on -X- _ O
in- -X- _ O
patient -X- _ O
services. -X- _ O
The -X- _ O
targeted -X- _ O
use -X- _ B-Intervention
of -X- _ I-Intervention
oxygen -X- _ I-Intervention
and -X- _ O
simple -X- _ O
, -X- _ O
non-invasive -X- _ O
methods -X- _ O
of -X- _ O
respiratory -X- _ O
support -X- _ O
may -X- _ O
be -X- _ O
a -X- _ O
highly -X- _ O
cost-effective -X- _ O
means -X- _ O
of -X- _ O
improving -X- _ O
outcome -X- _ O
, -X- _ O
but -X- _ O
the -X- _ O
optimal -X- _ O
oxygen -X- _ O
saturation -X- _ O
threshold -X- _ O
that -X- _ O
results -X- _ O
in -X- _ O
benefit -X- _ O
and -X- _ O
the -X- _ O
best -X- _ O
strategy -X- _ O
for -X- _ O
delivery -X- _ O
are -X- _ O
yet -X- _ O
to -X- _ O
be -X- _ O
tested -X- _ O
in -X- _ O
adequately -X- _ O
powered -X- _ O
randomised -X- _ O
controlled -X- _ O
trials. -X- _ O
There -X- _ O
is -X- _ O
, -X- _ O
however -X- _ O
, -X- _ O
an -X- _ O
accumulating -X- _ O
literature -X- _ O
about -X- _ O
the -X- _ O
harms -X- _ O
of -X- _ O
oxygen -X- _ B-Intervention
therapy -X- _ I-Intervention
across -X- _ O
a -X- _ O
range -X- _ O
of -X- _ O
acute -X- _ O
and -X- _ O
emergency -X- _ O
situations -X- _ O
that -X- _ O
have -X- _ O
stimulated -X- _ O
a -X- _ O
number -X- _ O
of -X- _ O
trials -X- _ O
investigating -X- _ O
permissive -X- _ O
hypoxia. -X- _ O
Methods -X- _ O
: -X- _ O
1. -X- _ O
Liberal -X- _ B-Intervention
oxygenation -X- _ I-Intervention
( -X- _ I-Intervention
recommended -X- _ I-Intervention
care -X- _ I-Intervention
) -X- _ I-Intervention
compared -X- _ I-Intervention
with -X- _ I-Intervention
a -X- _ I-Intervention
strategy -X- _ I-Intervention
that -X- _ I-Intervention
permits -X- _ I-Intervention
hypoxia -X- _ I-Intervention
to -X- _ I-Intervention
SpO -X- _ I-Intervention
( -X- _ I-Intervention
2 -X- _ I-Intervention
) -X- _ I-Intervention
> -X- _ I-Intervention
or -X- _ I-Intervention
= -X- _ I-Intervention
80 -X- _ I-Intervention
% -X- _ I-Intervention
( -X- _ I-Intervention
permissive -X- _ I-Intervention
hypoxia -X- _ I-Intervention
) -X- _ I-Intervention
; -X- _ I-Intervention
and -X- _ I-Intervention
2. -X- _ I-Intervention
High -X- _ I-Intervention
flow -X- _ I-Intervention
using -X- _ I-Intervention
AIrVO -X- _ I-Intervention
( -X- _ I-Intervention
2 -X- _ I-Intervention
) -X- _ I-Intervention
( -X- _ I-Intervention
TM -X- _ I-Intervention
) -X- _ I-Intervention
compared -X- _ I-Intervention
with -X- _ I-Intervention
low -X- _ I-Intervention
flow -X- _ I-Intervention
delivery -X- _ I-Intervention
( -X- _ I-Intervention
routine -X- _ I-Intervention
care -X- _ I-Intervention
) -X- _ I-Intervention
. -X- _ O
Discussion -X- _ O
: -X- _ O
The -X- _ O
overarching -X- _ O
objective -X- _ O
is -X- _ O
to -X- _ O
address -X- _ O
the -X- _ O
key -X- _ O
research -X- _ O
gaps -X- _ O
in -X- _ O
the -X- _ O
therapeutic -X- _ O
use -X- _ B-Intervention
of -X- _ I-Intervention
oxygen -X- _ I-Intervention
in -X- _ O
resource-limited -X- _ O
setting -X- _ O
in -X- _ O
order -X- _ O
to -X- _ O
provide -X- _ O
a -X- _ O
better -X- _ O
evidence -X- _ O
base -X- _ O
for -X- _ O
future -X- _ O
management -X- _ O
guidelines. -X- _ O
The -X- _ O
trial -X- _ O
has -X- _ O
been -X- _ O
designed -X- _ O
to -X- _ O
address -X- _ O
the -X- _ O
poor -X- _ O
outcomes -X- _ O
of -X- _ O
children -X- _ B-Patient
in -X- _ I-Patient
sub-Saharan -X- _ I-Patient
Africa -X- _ I-Patient
, -X- _ O
which -X- _ O
are -X- _ O
associated -X- _ O
with -X- _ O
high -X- _ O
rates -X- _ O
of -X- _ O
in-hospital -X- _ O
mortality -X- _ O
, -X- _ O
9-10 -X- _ B-Outcome
% -X- _ I-Outcome
( -X- _ I-Outcome
for -X- _ I-Outcome
those -X- _ I-Outcome
with -X- _ I-Outcome
oxygen -X- _ I-Outcome
saturations -X- _ I-Outcome
of -X- _ I-Outcome
80-92 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
26-30 -X- _ I-Outcome
% -X- _ I-Outcome
case -X- _ I-Outcome
fatality -X- _ I-Outcome
for -X- _ I-Outcome
those -X- _ I-Outcome
with -X- _ I-Outcome
oxygen -X- _ I-Outcome
saturations -X- _ I-Outcome
< -X- _ I-Outcome
80 -X- _ I-Outcome
% -X- _ I-Outcome
. -X- _ O
Clinical -X- _ O
trial -X- _ O
registration -X- _ O
: -X- _ O
ISRCTN15622505 -X- _ O
Trial -X- _ O
status -X- _ O
: -X- _ O
Recruiting -X- _ O

